相关实验视频

Updated: Jun 14, 2025

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

帕金森病与具有TET2突变的克隆性血液形成有关

Kyung Ah Woo¹, Han-Joon Kim², Chan Young Lee³

¹Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.

NPJ Parkinson's disease

|September 6, 2024

概括

帕金森病 (PD) 与不确定的潜力 (CHIP) 克隆性血液形成的更高患病率有关,特别是TET2突变. 这表明免疫系统的失调可能在PD的发展和进展中发挥作用.

科学领域:

血液学血液学血液学
神经科学是一个神经科学.
免疫学免疫学免疫学

背景情况:

不确定潜力的克隆造血 (CHIP) 涉及突变造血干细胞的前恶性扩张,并与免疫变化有关.
神经炎症和免疫功能障碍与帕金森病 (PD) 的病理生理学有关.

研究的目的:

调查CHIP与帕金森病之间的潜在关联.
探索CHIP患病率在PD患者中与对照组和孤立REM睡眠行为障碍 (iRBD) 患者相比是否有所不同.

主要方法:

在341名PD患者,92名iRBD患者和5003名对照患者的外周血液DNA上进行了与血液瘤相关的24个基因的向测序.
病例按运动进展速度 (快速,缓慢,典型) 分类.
多变量逻辑回归模型评估了与对照组的CHIP流行率 (≥1.0%变异性等位基因分数).

主要成果:

CHIP,特别是TET2突变,在PD患者中比对照患者更为普遍 (aOR 1.75,p=0.017).
这种关联在快速运动进展的PD小组中尤为强烈 (aOR 3.19,p=0.004).
在CHIP和iRBD之间没有发现显著的关联.

结论:

帕金森病与CHIP携带TET2突变的几率增加有关.
这些发现表明免疫失调在PD的潜在机制中可能发挥作用.
CHIP可以作为一种生物标志物或对PD病变发生的贡献者,特别是在快速进展的病例中.

更多相关视频

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase

Published on: October 15, 2018

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Hematopoiesis

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...